Home
CHRO
CHRO News

Latest Chromocell Therapeutics Corporation (CHRO) News on June 7, 2025

Roche extends trials of antibiotic against resistant superbug, FT reports

TipRanks

10 days ago

Roche extends trials of antibiotic against resistant superbug, FT reports

Tandem Diabetes, Roche enter patent settlement agreement

TipRanks

13 days ago

Tandem Diabetes, Roche enter patent settlement agreement

Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models

GlobeNewswire

24 days ago

Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models

EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models

Benzinga

24 days ago

EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

GlobeNewswire

a month ago

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

LGND: Pelthos To Become Public Company

Zacks Small Cap Research

a month ago

LGND: Pelthos To Become Public Company

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer Thursday Afternoon

MT Newswires

2 months ago

Update: Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics

MT Newswires

2 months ago

Top Midday Gainers

MT Newswires

2 months ago

Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

GlobeNewswire

2 months ago

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity

Benzinga

2 months ago

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity

Roche’s Genentech present data on trontinemab, Elecsys plasma test

TipRanks

2 months ago

Roche’s Genentech present data on trontinemab, Elecsys plasma test

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine

GlobeNewswire

6 months ago

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model

GlobeNewswire

6 months ago

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model

Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates

GlobeNewswire

7 months ago

Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

GlobeNewswire

7 months ago

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

Chromocell to Present at Upcoming Fall Investor Conferences

GlobeNewswire

7 months ago

Chromocell to Present at Upcoming Fall Investor Conferences

Chromocell Announces Amendment to Stock Repurchase Plan

GlobeNewswire

7 months ago

Chromocell Announces Amendment to Stock Repurchase Plan

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

GlobeNewswire

9 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

GlobeNewswire

9 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Chromocell to Participate in Life Sciences Investor Forum September 19th

GlobeNewswire

9 months ago

Chromocell to Participate in Life Sciences Investor Forum September 19th

Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

9 months ago

Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Chromocell Announces Stock Repurchase Plan

GlobeNewswire

10 months ago

Chromocell Announces Stock Repurchase Plan

Chromocell to Participate in the Virtual Investor Lunch Break Series

GlobeNewswire

a year ago

Chromocell to Participate in the Virtual Investor Lunch Break Series

Edge Total Intelligence Inc. Updates Status of MCTO

Newsfile

a year ago

Edge Total Intelligence Inc. Updates Status of MCTO

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

GlobeNewswire

a year ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

GlobeNewswire

a year ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

GlobeNewswire

a year ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

GlobeNewswire

a year ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

GlobeNewswire

a year ago

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

Chromocell Issues Letter to Stockholders from Chief Executive Officer

GlobeNewswire

a year ago

Chromocell Issues Letter to Stockholders from Chief Executive Officer

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

GlobeNewswire

a year ago

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

GlobeNewswire

a year ago

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

Sidoti Events, LLC's Virtual March Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual March Small-Cap Conference

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

GlobeNewswire

a year ago

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions

GlobeNewswire

a year ago

Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

GlobeNewswire

a year ago

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

GlobeNewswire

a year ago

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

Share on Social Networks: